论文部分内容阅读
目的探讨胺碘酮联合步长稳心颗粒治疗心律失常的临床效果。方法将我院收治的60例室性心律失常患者,随机分为对照组和观察组,两组均积极治疗原发病。对照组在此基础上加用胺碘酮治疗,观察组在对照组的基础上加用步长稳心颗粒治疗。分析两组治疗效果及不良反应发生情况。结果对照组总有效率73.3%,观察组总有效率90%。两组总有效率经统计学分析,差异有统计学意义(P<0.05)。对照组与观察组不良反应发生情况经统计学分析,差异无统计学意义(P>0.05)。结论胺碘酮联合步长稳心颗粒治疗心律失常疗效优于单用胺碘酮治疗,使用方便,不良反应少,值得临床推广应用。
Objective To investigate the clinical effect of Amiodarone combined with Step-stabilizing Granule in treating arrhythmia. Methods Sixty patients with ventricular arrhythmia admitted to our hospital were randomly divided into control group and observation group. Both groups were active in the treatment of primary disease. The control group was treated with amiodarone on the basis of the above, and the observation group was treated with Wenxin Granules on the basis of the control group. Analysis of two groups of treatment and adverse reactions occurred. Results The total effective rate was 73.3% in the control group and 90% in the observation group. The total effective rate of the two groups by statistical analysis, the difference was statistically significant (P <0.05). Adverse reactions in the control group and observation group were statistically analyzed, the difference was not statistically significant (P> 0.05). Conclusions Amiodarone combined with Stephensunxin Granule in the treatment of arrhythmia is superior to single amiodarone treatment. It is easy to use and has few adverse reactions. It is worthy of clinical application.